| Year |
Citation |
Score |
| 2023 |
Stieglitz E, Gu CJ, Richardson M, Kita R, Santaguida MT, Ali KA, Strachan DC, Dhar A, Yam G, Anderson W, Anderson E, Hübner J, Tasian SK, Loh ML, Lacher MD. Tretinoin Enhances the Effects of Chemotherapy in Juvenile Myelomonocytic Leukemia Using an Ex Vivo Drug Sensitivity Assay. Jco Precision Oncology. 7: e2300302. PMID 37944074 DOI: 10.1200/PO.23.00302 |
0.35 |
|
| 2022 |
Branstrom A, Cao L, Furia B, Trotta C, Santaguida M, Graci JD, Colacino JM, Ray B, Li W, Sheedy J, Mollin A, Yeh S, Kong R, Sheridan R, Baird JD, et al. Emvododstat, a Potent Dihydroorotate Dehydrogenase Inhibitor, Is Effective in Preclinical Models of Acute Myeloid Leukemia. Frontiers in Oncology. 12: 832816. PMID 35223511 DOI: 10.3389/fonc.2022.832816 |
0.372 |
|
| 2018 |
Aleshin A, Greenberg PL, Medeiros BC, Heiser D, Santaguida M, Prashad S, Durruthy-Durruthy R, Eastburn DJ. Abstract 3004: Single-cell mutational profiling of clonal evolution in myelodysplastic syndromes (MDS) during therapy and disease progression Cancer Research. 78: 3004-3004. DOI: 10.1158/1538-7445.Am2018-3004 |
0.459 |
|
| 2015 |
Damelin M, Bankovich A, Park A, Aguilar J, Anderson W, Santaguida M, Aujay M, Fong S, Khandke K, Pulito V, Ernstoff E, Escarpe P, Bernstein J, Pysz M, Zhong W, et al. Anti-EFNA4 Calicheamicin Conjugates Effectively Target Triple-Negative Breast and Ovarian Tumor-Initiating Cells to Result in Sustained Tumor Regressions. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26015513 DOI: 10.1158/1078-0432.Ccr-15-0695 |
0.308 |
|
| 2015 |
Damelin M, Bankovich A, Park A, Aguilar J, Anderson W, Santaguida M, Fong S, Aujay M, Khandke K, Pulito V, Ernstoff E, Escarpe P, Bernstein J, Pysz MA, Zhong W, et al. Abstract 5425: An anti-Ephrin-A4 calicheamicin conjugate effectively targets triple-negative breast and ovarian tumor-initiating cells to result in sustained tumor regression Cancer Research. 75: 5425-5425. DOI: 10.1158/1538-7445.Am2015-5425 |
0.328 |
|
| 2010 |
Sansregret L, Gallo D, Santaguida M, Leduy L, Harada R, Nepveu A. Hyperphosphorylation by cyclin B/CDK1 in mitosis resets CUX1 DNA binding clock at each cell cycle. The Journal of Biological Chemistry. 285: 32834-43. PMID 20729212 DOI: 10.1074/Jbc.M110.156406 |
0.382 |
|
| 2009 |
Santaguida M, Schepers K, King B, Sabnis AJ, Forsberg EC, Attema JL, Braun BS, Passegué E. JunB protects against myeloid malignancies by limiting hematopoietic stem cell proliferation and differentiation without affecting self-renewal. Cancer Cell. 15: 341-52. PMID 19345332 DOI: 10.1016/J.Ccr.2009.02.016 |
0.637 |
|
| 2009 |
Sabnis AJ, Cheung LS, Dail M, Kang HC, Santaguida M, Hermiston ML, Passegué E, Shannon K, Braun BS. Oncogenic Kras initiates leukemia in hematopoietic stem cells. Plos Biology. 7: e59. PMID 19296721 DOI: 10.1371/Journal.Pbio.1000059 |
0.622 |
|
| 2008 |
Santaguida MT, Schepers K, King BC, Passegue E. JunB Limits Hematopoietic Stem Cell (HSC) Functions as a Protective Mechanism against Initiation of Myeloid Malignancy Blood. 112: 1358-1358. DOI: 10.1182/Blood.V112.11.1358.1358 |
0.663 |
|
| 2007 |
Santaguida M, Schepers K, King B, Passegue E. Deciphering JunB Function in Regulating Hematopoietic Stem Cell Functions. Blood. 110: 777-777. DOI: 10.1182/Blood.V110.11.777.777 |
0.638 |
|
| 2002 |
Moon NS, Rong Zeng W, Premdas P, Santaguida M, Bérubé G, Nepveu A. Expression of N-terminally truncated isoforms of CDP/CUX is increased in human uterine leiomyomas. International Journal of Cancer. 100: 429-32. PMID 12115525 DOI: 10.1002/Ijc.10510 |
0.344 |
|
| Show low-probability matches. |